These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1581441)

  • 21. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.
    Balldin J; Granérus AK; Lindstedt G; Modigh K; Wålinder J
    Psychopharmacology (Berl); 1982; 76(4):371-6. PubMed ID: 6812112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone pattern and post-treatment attitudes in patients with major depressive disorder given electroconvulsive therapy.
    Apéria B
    Acta Psychiatr Scand; 1986 Mar; 73(3):271-4. PubMed ID: 3012951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which patients will respond to ECT?
    Yatham LN; Barry S; Dinan TG; Webb M
    Br J Psychiatry; 1989 Jun; 154():879-80. PubMed ID: 2597898
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients.
    Christie JE; Whalley LJ; Brown NS; Dick H
    Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness.
    Apéria B; Bergman H; Engelbrektson K; Thorén M; Wetterberg L
    Acta Psychiatr Scand; 1985 Dec; 72(6):536-41. PubMed ID: 3002132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome.
    Deakin JF; Ferrier IN; Crow TJ; Johnstone EC; Lawler P
    Br J Psychiatry; 1983 Dec; 143():618-24. PubMed ID: 6661605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release.
    Papakostas Y; Markianos M; Papadimitriou G; Stefanis C
    Psychopharmacology (Berl); 1990; 100(2):206-8. PubMed ID: 2106150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing prolactin release induced by electroconvulsive therapy.
    Balldin J
    Acta Psychiatr Scand; 1982 May; 65(5):365-9. PubMed ID: 7113733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminished TSH release after a course of ECT: altered monoamine function or seizure activity?
    Scott AI; Milner JB; Shering PA
    Psychoneuroendocrinology; 1989; 14(6):425-31. PubMed ID: 2623133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy.
    Scott AI; Whalley LJ; Bennie J; Bowler G
    Lancet; 1986 Jun; 1(8495):1411-4. PubMed ID: 2872518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine predictors of electroconvulsive therapy outcome. Dexamethasone suppression test and prolactin.
    Fink M
    Ann N Y Acad Sci; 1986; 462():30-6. PubMed ID: 3518572
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy.
    Zis AP; Yatham LN; Lam RW; Clark CM; Srisurapanont M; McGarvey K
    Neuropsychopharmacology; 1996 Sep; 15(3):263-70. PubMed ID: 8873109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage.
    Lisanby SH; Devanand DP; Prudic J; Pierson D; Nobler MS; Fitzsimons L; Sackeim HA
    Biol Psychiatry; 1998 Jan; 43(2):146-55. PubMed ID: 9474447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic mechanisms of ECT: neuroendocrine evidence.
    Shapira B; Newman M; Lerer B
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():673A-674A. PubMed ID: 1498996
    [No Abstract]   [Full Text] [Related]  

  • 36. Ictal EEG regularity declines during a course of RUL ECT.
    McCall WV; Colenda CC; Farah BA
    Convuls Ther; 1996 Dec; 12(4):213-6. PubMed ID: 9034695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triazolam and diphenhydramine effects on seizure duration in depressed patients receiving ECT.
    Guthrie SK; Sung JC; Goodson J; Grunhaus L; Tandon R
    Convuls Ther; 1996 Dec; 12(4):261-5. PubMed ID: 9034702
    [No Abstract]   [Full Text] [Related]  

  • 38. Response of depressed patients to sequential unilateral nondominant brief-pulse and bilateral sinusoidal ECT.
    Price TR; McAllister TW
    J Clin Psychiatry; 1986 Apr; 47(4):182-6. PubMed ID: 3957877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major depressive disorder in patients with the implantable cardioverter defibrillator. Two cases treated with ECT.
    Goldberg RJ; Badger JM
    Psychosomatics; 1993; 34(3):273-7. PubMed ID: 8493312
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaesthetic technique in the practice of ECT.
    Collins IP; Scott IF
    Br J Psychiatry; 1995 Jan; 166(1):118-9. PubMed ID: 7894864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.